Literature DB >> 18508627

The tumor antigen EpCAM: tetraspanins and the tight junction protein claudin-7, new partners, new functions.

Francois Le Naour1, Margot Zoller.   

Abstract

The cell-cell adhesion molecule EpCAM/CD326 has been one of the first tumor-associated antigens and has soon received attention as an antibody target in cancer therapy. However, only recently, progress has been achieved in disclosing the array of functional activities of EpCAM and the underlying molecular mechanisms. This review will particularly focus on cooperative activity of EpCAM with two classes of transmembrane molecules, tetraspanins and claudins. EpCAM can associate with claudin-7 and the tetraspanins CD9 and CO-029. We propose that complex formation of EpCAM with tetraspanins and claudins does not only interfere with EpCAM-mediated homotypic cell-cell adhesion, but importantly, is also associated with a gain of function, like induction of apoptosis resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508627     DOI: 10.2741/3121

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  15 in total

1.  Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.

Authors:  Vera Novitskaya; Hanna Romanska; Marwa Dawoud; J Louise Jones; Fedor Berditchevski
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 2.  Physiology and function of the tight junction.

Authors:  James M Anderson; Christina M Van Itallie
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

3.  Thymic stromal lymphopoietin induces tight junction protein claudin-7 via NF-kappaB in dendritic cells.

Authors:  Ryuta Kamekura; Takashi Kojima; Akira Takashima; Jun-ichi Koizumi; Noriko Ogasawara; Mitsuru Go; Ken-ichi Takano; Masaki Murata; Satoshi Tanaka; Shingo Ichimiya; Tetsuo Himi; Norimasa Sawada
Journal:  Histochem Cell Biol       Date:  2010-03       Impact factor: 4.304

4.  Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.

Authors:  Bow J Tauro; David W Greening; Rommel A Mathias; Suresh Mathivanan; Hong Ji; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2012-12-10       Impact factor: 5.911

Review 5.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

6.  Aberrant expression of claudin-4 and -7 in hepatocytes in the cirrhotic human liver.

Authors:  Mitsuhiro Tsujiwaki; Masaki Murata; Akira Takasawa; Yutaro Hiratsuka; Rieko Fukuda; Kotaro Sugimoto; Yusuke Ono; Masanori Nojima; Satoshi Tanaka; Koichi Hirata; Takashi Kojima; Norimasa Sawada
Journal:  Med Mol Morphol       Date:  2014-04-16       Impact factor: 2.309

7.  Molecular characterization of a fully human chimeric T-cell antigen receptor for tumor-associated antigen EpCAM.

Authors:  Naoto Shirasu; Hiromi Yamada; Hirotomo Shibaguchi; Motomu Kuroki; Masahide Kuroki
Journal:  J Biomed Biotechnol       Date:  2012-04-03

8.  Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.

Authors:  Neetu Dahiya; Kevin G Becker; William H Wood; Yongqing Zhang; Patrice J Morin
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

9.  The importance of claudin-7 palmitoylation on membrane subdomain localization and metastasis-promoting activities.

Authors:  Sarah Heiler; Wei Mu; Margot Zöller; Florian Thuma
Journal:  Cell Commun Signal       Date:  2015-06-09       Impact factor: 5.712

Review 10.  EpCAM and the biology of hepatic stem/progenitor cells.

Authors:  Laurent Dollé; Neil D Theise; Eva Schmelzer; Luke Boulter; Olivier Gires; Leo A van Grunsven
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.